Search results
Results from the WOW.Com Content Network
The systems of the body most affected by chemotherapy drugs include visual and semantic memory, attention and motor coordination and executive functioning. [9] [10] These effects can impair a chemotherapy patient's ability to understand and make decisions regarding treatment, perform in school or employment and can reduce quality of life. [10]
Chemotherapy-induced acral erythema, also known as palmar-plantar erythrodysesthesia or hand-foot syndrome is reddening, swelling, numbness and desquamation (skin sloughing or peeling) on palms of the hands and soles of the feet (and, occasionally, on the knees, elbows, and elsewhere) that can occur after chemotherapy in patients with cancer.
Delayed: occurring between 24 hours and 5 days after treatment; Breakthrough: occurring despite prophylactic treatment; Anticipatory: triggered by taste, odor, memories, visions, or anxiety related to chemotherapy; Refractory: occurring during subsequent cycles when antiemetics have failed in earlier cycles
The post Dick Vitale Reveals What Doctors Told Him About Post-Chemo Recovery appeared first on The Spun. The college basketball commentator has dealt with multiple medical issues as of late, but ...
Many chemotherapy symptoms are temporary, but it can take the body months, for some years, to recover from changes. Most people may need around six to 12 months to fully recover.
Motor and autonomic symptoms are less frequent but possible. Symptoms may start days after the patient receives their first dose of chemotherapy, are dose dependent, and tend to improve after completion of treatment. However, in some cases, symptoms can persist six months or later following the completion of chemotherapy. [8]
At Memorial Sloan Kettering Cancer Center in NYC, ready for my second round of chemotherapy. I had only four glorious days with my bob before starting chemo. But even three weeks in, I still had ...
This occurs most commonly after the treatment of lymphomas and leukemias and in particular when treating non-Hodgkin lymphoma, acute myeloid leukemia, and acute lymphoblastic leukemia. [ 2 ] [ 3 ] This is a potentially fatal complication and people at an increased risk for TLS should be closely monitored while receiving chemotherapy and should ...